Novo Nordisk A/S (0QIU.IL)
IOB - IOB Delayed price. Currency in DKK
Add to watchlist
At close: 07:12PM BST
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
244,243,000
232,261,000
176,954,000
140,800,000
126,946,000
Cost of revenue
37,499,000
35,765,000
28,448,000
23,658,000
20,932,000
Gross profit
206,744,000
196,496,000
148,506,000
117,142,000
106,014,000
Operating expenses
Research development
34,321,000
32,443,000
24,047,000
17,772,000
15,462,000
Selling general and administrative
62,528,000
61,598,000
50,684,000
41,058,000
36,886,000
Total operating expenses
97,331,000
93,922,000
73,697,000
58,498,000
51,888,000
Operating income or loss
109,413,000
102,574,000
74,809,000
58,644,000
54,126,000
Interest expense
1,494,000
542,000
378,000
289,000
390,000
Total other income/expenses net
-
1,770,000
-5,427,000
616,000
-793,000
Income before tax
111,855,000
104,674,000
69,062,000
59,080,000
53,130,000
Income tax expense
22,579,000
20,991,000
13,537,000
11,323,000
10,992,000
Income from continuing operations
89,276,000
83,683,000
55,525,000
47,757,000
42,138,000
Net income
89,276,000
83,683,000
55,525,000
47,757,000
42,138,000
Net income available to common shareholders
89,276,000
83,683,000
55,525,000
47,757,000
42,138,000
Basic EPS
16.77
18.67
12.26
10.40
9.03
Diluted EPS
16.72
18.62
12.22
10.37
9.01
Basic average shares
4,493,493
4,482,800
4,530,600
4,593,200
4,667,800
Diluted average shares
4,506,800
4,494,800
4,544,600
4,606,200
4,680,000
© 2024 Yahoo. All rights reserved.